Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Sanford-Burnham, Mayo join forces
April 2013
SHARING OPTIONS:

LA JOLLA, Calif.A new collaborative agreement was signed between Sanford-Burnham Medical Research Institute and Mayo Clinic for the development of a pipeline of therapeutic drugs aimed at a variety of diseases. Per the agreement, Mayo Clinic scientists and researchers in Sanford-Burnham's Conrad Prebys Center for Chemical Genomics will work together to conduct early-stage drug discovery, including assay development, high-throughput screening and lead identification. This arrangement builds on a yearlong pilot phase and expands on the number and range of drug discovery projects derived from Mayo Clinic scientists and conducted at Sanford-Burnham.  
 
"The Mayo Clinic-Sanford-Burnham collaboration provides an avenue for Mayo scientists to rapidly translate basic science discoveries into screening platforms that will enable new drug discovery and a new paradigm in drug development," said Dr. Andrew Badley, associate dean of research resources at Mayo Clinic.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.